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Professor of Medicine, Case Western Reserve University School of Medicine, Cleveland, OHOSTEOARTHRITIS can be considered a collective end-
stage for heterogeneous etiopathologic conditions
a#ecting joint tissues. Such etiopathologic factors
are multifactorial and include biochemical, enzy-
matic, genetic and biomechanical factors amongst
others. Characteristic pathologic findings include
joint space narrowing, peripheral osteophytes,
subchondral bony sclerosis and cyst formation.
Although commonly considered a disease
primarily involving cartilage, studies support
variable roles for synovium, muscle, ligaments and
bone. Radin and co-workers [1, 2] suggested an
important role for subchondral bone changes as an
etiologic factor in the early development of degen-
erative joint disease. Repetitive impulsive loading
resulted in early responses characterized by
increased bone formation, associated with relative
sti#ening of bone; articular cartilage degeneration
followed [3]. Subchondral bone changes preceding
cartilage damage in osteoarthritis have been dem-
onstrated in other animal models. Examination of
trabecular bone within the femoral head of
Hartley strain guinea pigs, a strain predisposed to
osteoarthritis, demonstrated subchondral trabecu-
lar remodeling as an early event in this model of
OA [4]. Serial observations in this model utilizing
magnetic resonance imaging revealed significant
progression of subchondral sclerosis as well as
osteophytes during disease development [5].
A longitudinal study of subchondral bone
responses in dogs undergoing anterior cruciate
ligament transection revealed subchondral scler-
osis at 18 months and 54 months, but not at
3 months; findings were associated with loss of
subchondral trabecular bone at all three time
points. Findings suggested that bony changes were
associated with progression of cartilage degener-
ation, rather than initial development [6]. Exper-
imentally induced osteoarthritis following partial
meniscectomy (PM) in the rabbit was associated
with prominent osteophyte formation [7].
Increased cellular replication was noted early (at323two weeks) in subchondral bone, but had returned
to normal by five weeks post PM. Increased meta-
bolic changes were noted simultaneously in areas
of cartilage as well as in subchondral bone at the
two week period post mortem. No evidence of
subchondral sclerosis was noted on routine
microscopy. Accordingly, in various animal
models, bone response is characterized by
subchondral bony sclerosis and osteophyte
formation simulating that seen in idiopathic
osteoarthritis in humans.
The pathophysiologic mechanisms whereby
bony responses occur in OA have yet to be pre-
cisely defined. In human studies, serum insulin
levels were increased, and insulin-like growth
factor-1 (IGF-1) decreased in patients with osteo-
arthritis [8]. Osteoblast-like cells from human
subchondral osteoarthritic bone revealed
increases in IGF-1 release [9]. Transforming
growth factor–â1 (TGF-â1) was shown to stimulate
articular chondrocyte proteoglycan synthesis and
to induce osteophyte formation in the murine knee
joint [10]. Osteophyte formation in the rabbit PM
model was associated with an upregulation of
fibroblast-growth factor-R3 (FGF-R3) receptor at
four weeks, with diminished levels noted at eight
weeks during osteophyte formation [11]. Increases
in sialoprotein serum levels associated with pro-
gression of OA in humans suggests involvement of
subchondral bone in developing disease [12].
Altered gene responses of cells to mechanical
loading likely play a significant role in adaptative
remodeling of the joint to meet changing mechan-
ical demands; bone as a tissue can adapt its mass
and architecture through remodeling (Wolf’s
Law). Changes in synthetic phenotypes seen in
human subchondral osteoarthritic bone [13] are
consistent with such mechanical responses.
Clinical observations and experimental investi-
gations, as noted above, support a role for bone
responses in the overall osteoarthritic process.
The more specific question relates as to whether
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initiation, or whether bony changes play a role in
the osteoarthritic process once it has evolved.
Current studies suggest that, although bone may
exhibit an early metabolic response, the chondro-
cyte plays a more important role in disease process
initiation (Fig. 1). Early findings of increased
chondrocyte synthetic activity in osteoarthritic
cartilage, characterized by increased formation of
matrix proteoglycans, collagen and hyaluronic
acid, are consistent with a primary role for
growth factor-related stimulation. Later, release
of cytokines from synovium and cartilage leads
to catabolic cartilage degradation. Increased
subchondral bone responses related to growth
factors augment the osteoarthritic process with
altered biomechanical stresses across the joint.
In summary, osteoarthritis is characterized by
subchondral bony sclerosis, and proliferative bone
responses associated with osteophyte formation.
Studies suggest that subchondral bone responses
may play a role in disease progression, as opposed
to disease initiation/development. Osteophyte for-
mation may play a compensatory role in redistri-
bution of forces to provide articular cartilage
protection.FIG. 1. Schema of interplay between cartilage and bone
in the etiopathogenesis of osteoarthritis.References
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